- Tytuł:
- Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
- Autorzy:
- Źródło:
- In The Lancet Regional Health - Europe March 2024 38
Czasopismo naukowe